Len Schleifer and George Yan­copou­los once again land in the top ranks of the high­est paid ex­ecs in bio­phar­ma

Len Schleifer and George Yan­copou­los clear­ly en­joy the com­pen­sa­tion course they’ve set for them­selves over the last few years. This year Re­gen­eron’s CEO and re­search czar — chief doesn’t cut it any­more — grabbed pack­ages of stock awards $REGN and op­tions that pushed the to­tal up to $26.5 mil­lion and $25.4 mil­lion, re­spec­tive­ly.

The Re­gen­eron co-founders are among the most ag­gres­sive biotech play­ers in the in­dus­try, and they’ve paid them­selves among the high­est com­pen­sa­tion rates in the in­dus­try for years now.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER